Obesity

17 competing products in clinical development for Obesity.

Pipeline by Phase

Phase 17

Phase 25

Phase 33

Approved2

All Products (17)

Product	Company	Stage	Status	Hype
exenatide + Placebo	Eli Lilly	Approved	Completed	85
Tirzepatide	Eli Lilly	Approved	Recruiting	85
MK0557	Merck	Phase 3	Completed	77
Orforglipron + Placebo	Eli Lilly	Phase 3	Recruiting	77
Tirzepatide + Placebo	Eli Lilly	Phase 3	Completed	77
MK0493	Merck	Phase 2	Completed	52
Bimagrumab + Tirzepatide + Bimagrumab Placebo + Tirzepatide Placebo	Eli Lilly	Phase 2	Active	52
Tirzepatide	Eli Lilly	Phase 2	Recruiting	52
Oral Azelaprag (BGE-105) + Oral Placebo for Azelaprag (BGE-105) + Tirzepatide + Tirzepatide Placebo	Eli Lilly	Phase 2	Terminated	52
Nimacimab injection + Nimacimab placebo injection + Nimacimab 300 mg injection	Skye Bioscience	Phase 2	Active	44
Brenipatide	Eli Lilly	Phase 1	Recruiting	33
Orforglipron + Placebo	Eli Lilly	Phase 1	Completed	33
Eloralintide + Placebo	Eli Lilly	Phase 1	Completed	33
LY3437943 + Midazolam + Warfarin + Caffeine	Eli Lilly	Phase 1	Completed	33
AMG 786	Amgen	Phase 1	Completed	32
MBX 4291 + Placebo	MBX Biosciences	Phase 1	Recruiting	28
PG-102	Rani Therapeutics	Phase 1	Recruiting	25